Text this: Cost-effectiveness of dipeptidyl peptidase-4 inhibitor monotherapy versus sulfonylurea monotherapy for people with type 2 diabetes and chronic kidney disease in Thailand

 _____       ___      _____     _____     _  __  
|  __ \\    / _ \\   |__  //   |  ___||  | |/ // 
| |  \ ||  / //\ \\    / //    | ||__    | ' //  
| |__/ || |  ___  ||  / //__   | ||__    | . \\  
|_____//  |_||  |_|| /_____||  |_____||  |_|\_\\ 
 -----`   `-`   `-`  `-----`   `-----`   `-` --`